Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

ChemoCentryx, Inc

+1 (650) 210-2900
Website

Advertisement

Advertisement

Photos

835 Industrial Rd Ste 600
San Carlos, CA 94070
+1 (650) 210-2900
https://www.chemocentryx.com
Founded in 1997, ChemoCentryx is a clinical-based pharmaceutical company that discovers and develops orally-administered small molecule therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. It has developed EnabaLink, which is a drug recovery technology that is designed to accelerate productive drug recovery program. The company also conducts preclinical evaluation of a series of anticancer compounds that target the CXCR7 chemokine receptor. ChemoCentryx evaluates a series of compounds that target the C5a chemo-attractant receptor to treat age-related macular degeneration, rheumatoid arthritis and systemic lupus erythematosus and other disorders. It has entered into a strategic alliance with Glaxo Group, which is an affiliate of GlaxoSmithKline. ChemoCentryx maintains its headquarters in Mountain View, Calif.

Also at this address

CARGO Therapeutics, Inc

Atreca

Nautilus Biotechnology

Own this business?
Claim it
See a problem?

You might also like

Alumis Inc

Alumis provides precision medicines. They transform the lives of patients with autoimmune diseases. They bring a proven track record in precision drug development of groundbreaking therapies. They rewrite the autoimmune treatment playbook with a unique precision analytics platform to advancing their understanding of immunologic diseases. They build a pipeline of therapeutics based on genetically validated targets for application in the treatment of multiple autoimmune disease indications.
Ultragenyx Pharmaceutical Inc
Sizes, Nonresidential construction, nec, nec, Testing laboratories

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc, based in Novato, is at the forefront of rare disease medicine, dedicated to advancing the rare disease community. With a commitment to progress and innovation, Ultragenyx is shaping the future of healthcare for those with rare diseases. Driven by a mission to propel the rare disease field forward, Ultragenyx Pharmaceutical Inc is a leader in developing treatments and therapies for those in need. Their focus on rare diseases underscores their dedication to improving the lives of patients and caregivers worldwide. Generated from their website's infomation
Drugs acting on the respiratory system

Meissa Vaccines Inc

Meissa Vaccines Inc is a biotechnology company based in Redwood City, CA, dedicated to developing live attenuated vaccines for respiratory viruses such as RSV and COVID-19. Their innovative technologies, including the proprietary AttenuBlock platform, aim to deliver effective vaccines globally, preventing infection and generating a strong immune response. With a mission to safeguard people worldwide from life-threatening respiratory viruses, Meissa Vaccines focuses on developing safe and highly attenuated vaccine candidates that induce a better immune response than natural infection. Their RSV and COVID-19 vaccine candidates are designed to provide a durable immune response by stimulating mucosal IgA and serum neutralizing antibodies.Generated from the website
United States›California›San Carlos›ChemoCentryx, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell